SPS
WVE icon

Susquehanna Portfolio Strategies’s Wave Life Sciences WVE Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Sell
195,840
-34,672
-15% -$452K 0.02% 571
2025
Q4 		$3.92M Sell
230,512
-74,862
-25% -$761K 0.06% 348
2025
Q3 		$2.24M Buy
305,374
+20,288
+7% +$164K 0.04% 490
2025
Q2 		$1.85M Buy
285,086
+270,758
+1,890% +$1.79M 0.04% 390
2025
Q1 		$116K Buy
+14,328
New +$157K 0.05% 144

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Susquehanna Portfolio Strategies's WVE Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Wave Life Sciences (WVE) stake by 15% in Q1 2026, selling an estimated $452K and leaving 195,840 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #571.

Susquehanna Portfolio Strategies first reported a position in WVE in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.92M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Susquehanna Portfolio Strategies held 195,840 shares of Wave Life Sciences worth $1.42M as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 34,672 Wave Life Sciences shares in Q1 2026, an estimated $452K.
  • Wave Life Sciences made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #571 holding.
  • Susquehanna Portfolio Strategies first reported a position in Wave Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Wave Life Sciences position peaked at $3.92M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.